Chief, Renal Division and Associate Professor of Medicine, Washington University in St. Louis School of Medicine
Nephrology
Dr. Benjamin D. Humphreys, MD
|
|
Give Review
Benjamin Humphreys works in the field of Nephrology. He went to medical school at Case Western Reserve University School of Medicine. He has 2 awards "Member" and "Fellow (ASNF)". Dr. Benjamin D. Humphreys is a published doctor as well. He has 55 publications published. The latest was: Targeting Endogenous Repair Pathways after AKI. He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Targeting Endogenous Repair Pathways after AKI.
- Mammalian Target of Rapamycin Mediates Kidney Injury Molecule 1-Dependent Tubule Injury in a Surrogate Model.
- Pharmacological GLI2 inhibition prevents myofibroblast cell-cycle progression and reduces Kidney fibrosis.
- Perivascular Gli1(+) Progenitors Are Key Contributors to Injury-Induced Organ Fibrosis.
- Wnt signaling in Kidney tubulointerstitium during disease.
- Who regenerates the Kidney tubule?
- Report on ISN Forefronts, Florence, Italy, 12-15 September 2013: stem cells and Kidney regeneration.
- Discovery of new glomerular Disease-relevant genes by translational profiling of podocytes in vivo.
- The Seen and the Unseen: Clinical Guidelines and Cost-Effective Care.
- Fluorescence Microangiography for Quantitative Assessment of Peritubular Capillary Changes after AKI in Mice.
- Translational Profiles of Medullary Myofibroblasts during Kidney Fibrosis.
- CDK4/6 inhibition induces epithelial cell cycle arrest and ameliorates Acute kidney injury.
- Kidney injury, stem cells and regeneration.
- Defining Kidney Biology to Understand Renal Disease.
- Kidney structures differentiated from stem cells.
- Controversies on the origin of proliferating epithelial cells after Kidney injury.
- Lineage-tracing methods and the Kidney.
- Differentiated Kidney epithelial cells repair injured proximal tubule.
- Understanding the origin, activation and regulation of matrix-producing myofibroblasts for treatment of fibrotic Disease.
- Wnt4/β-Catenin Signaling in Medullary Kidney Myofibroblasts.
- TIM Family Proteins Promote the Lysosomal Degradation of the Nuclear Receptor NUR77.
- Targeting pericyte differentiation as a strategy to modulate Kidney fibrosis in diabetic nephropathy.
- Onco-Nephrology: AKI in the Cancer Patient.
- Regorafenib Induces Rapid and Reversible Changes in Plasma Nitric Oxide and Endothelin-1.
- Hedgehog-Gli Pathway Activation during Kidney Fibrosis.
- Targeted proximal tubule injury triggers interstitial fibrosis and glomerulosclerosis.
- Characterization and Fate of Telomerase-expressing Epithelia during Kidney Repair.
- Effects of novel angiogenesis inhibitors for the treatment of cancer on the cardiovascular system: focus on Hypertension.
- Pyrimethamine inhibits adult polycystic Kidney disease by modulating STAT signaling pathways.
- Repair of injured proximal tubule does not involve specialized progenitors.
- Origin of new cells in the adult Kidney: results from genetic labeling techniques.
- The origin of interstitial myofibroblasts in chronic Kidney disease.
- The spectrum of Kidney involvement in lymphoma: a case report and review of the literature.
- Suppression of the nitric oxide pathway in metastatic Renal cell carcinoma patients receiving vascular endothelial growth factor-signaling inhibitors.
- Hypertension induced by vascular endothelial growth factor signaling pathway inhibition: mechanisms and potential use as a biomarker.
- Onco-nephrology: Kidney disease in the cancer patient: introduction.
- Kidney disease associated with plasma cell dyscrasias.
- Rapid development of hypertension and proteinuria With cediranib, an oral vascular endothelial growth factor receptor inhibitor.
- Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in Kidney fibrosis.
- Cediranib, an oral inhibitor of vascular endothelial growth factor receptor kinases, is an active drug in recurrent epithelial ovarian, fallopian tube, and peritoneal ...
- Slow-cycling cells in Renal papilla: stem cells awaken?
- Rapid development of Hypertension by sorafenib: toxicity or target?
- CSF-1 signals directly to Renal tubular epithelial cells to mediate repair in mice.
- Adverse renal and metabolic effects associated With oral sodium phosphate bowel preparation.
- The case / progressive Hypertension and proteinuria on anti-angiogenic therapy.
- Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells.
- Intrinsic epithelial cells repair the Kidney after injury.
- A preeclampsia-like syndrome characterized by reversible Hypertension and proteinuria induced by the multitargeted kinase inhibitors sunitinib and sorafenib.
- Mesenchymal stem cells in Acute kidney injury.
- Shedding of the urinary biomarker Kidney injury molecule-1 (KIM-1) is regulated by MAP kinases and juxtamembrane region.
- Acetaminophen-induced anion gap metabolic Acidosis and 5-oxoprolinuria (pyroglutamic aciduria) acquired in hospital.
- Renal Failure associated with cancer and its treatment: an update.
- Gemcitabine-associated thrombotic microangiopathy.
- A population of selected Renal cells augments Renal function and extends survival in the ZSF1 model of progressive diabetic nephropathy.
Schools
Case Western Reserve University School of Medicine
Massachusetts General Hospital
Procedures Preformed
- Hemodialysis
Conditions Treated
- Acidosis
- Acute Glomerulonephritis
- Acute Kidney Failure
- Amyloidosis
- View All
Doctors Specialties
- Nephrology
Accepted Insurances
Awards
- Member
- Fellow (ASNF)
Education
-
Brigham and Women's Hospital -
Massachusetts General Hospital -
Case Western Reserve University School of Medicine
Hospital
-
Barnes-Jewish Hospital
Drug Facts
| NPI NUMBER | 1497798169 | |
| NPPES Provider LastName | HUMPHREYS | |
| NPPES Provider FirstName | BENJAMIN | |
| NPPES Provider ZIPCode | 02115 | |
| NPPES Provider State | MA | |
| Specialty Description | Nephrology | |
| Total Claim Count | 176.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1497798169 |
| Last Name Of The Provider | HUMPHREYS |
| First Name Of The Provider | BENJAMIN |
| View All |
Similar Doctors
|
|
Dr. Matthew B. Rivara, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Herbert Y. Lin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Albert Q. Lam, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Candace D. Wang, MD |
|
|
Dr. Christiane J. Ferran, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Kassem Safa, MD |
|
|
Dr. John A. D'Elia, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Craig E. Gordon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alin A. John, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tal H. Kopel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eva B. Long, MD |